Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide in Children Aged 6-12 Years With Severe Obesity
NCT07590219Phase 4Active, not recruiting
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Mar 2024
- Primary completion
- Apr 2027
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in obesity, sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Started Mar 2024; status: active, not recruiting.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07590219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07590219.